Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53.

Urology - 1 Mar 1996

Stricker H J, Jay J K, Linden M D, Tamboli P, Amin M B

Abstract excerpt

OBJECTIVES: Mutations of the p53 tumor suppressor gene can result in unregulated cellular growth and have been implicated in numerous malignancies. The objective of this study was to determine whether the detection of mutant p53 by immunohistochemical staining is predictive of progression in clinically localized adenocarcinoma of the prostate. METHODS: Immunohistochemical staining for mutant p53 was performed on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p53

Share to Immunohistochemistry

Share to Mutation

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 8633403
DOI: 10.1016/S0090-4295(99)80454-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53.PMID 8633403Read ↗

Clinical significance of p53 alterations in surgically treated prostate cancers.Semantic proximity Read ↗

Frequency and characterization of p53 mutations in clinically localized prostate cancer.Semantic proximity Read ↗

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.Semantic proximity Read ↗

Evaluation of the Prognostic Role of TP53 Gene Mutations in Prostate Cancer Outcome: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations.Semantic proximity Read ↗

Prognostic significance of Bcl-2 in clinically localized prostate cancer.Semantic proximity Read ↗

p53, bcl-2 and Retinoblastoma Proteins as Long-Term Prognostic Markers in Localized Carcinoma of the ProstateSemantic proximity Read ↗

A modified yeast assay used on archival samples of localized prostate cancer tissue improves the detection of p53 abnormalities and increases their predictive value.Semantic proximity Read ↗

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerSemantic proximity Read ↗

Overexpression of p53 in prostate carcinoma is associated with improved overall survival but not predictive of response to radiotherapy.Semantic proximity Read ↗

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.Semantic proximity Read ↗

Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.